Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial-Reference-Cited by-同舟云学术

Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial

Published:2014-12 Issue:1 Volume:9 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Yahya Noorazrul,Ebert Martin A,Bulsara Max,Haworth Annette,Kearvell Rachel,Foo Kerwyn,Kennedy Angel,Richardson Sharon,Krawiec Michele,Joseph David J,Denham Jim W

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-014-0282-7.pdf

Reference39 articles.

1. Roelofs E, Persoon L, Qamhiyeh S, Verhaegen F, De Ruysscher D, Scholz M, Iancu G, Engelsman M, Rasch C, Zijp L, Meerleer GD, Coghe M, Langendijk J, Schilstra C, Pijls-Johannesma M, Lambin P: Design of and technical challenges involved in a framework for multicentric radiotherapy treatment planning studies. Radiother Oncol 2010, 97: 567-571. 10.1016/j.radonc.2010.08.009

2. Antonella F, Eugenio V, Dirk A, Carsten B, Alessandro C, Tommy K, Giorgia N, Luca C: On the dosimetric behaviour of photon dose calculation algorithms in the presence of simple geometric heterogeneities: comparison with Monte Carlo calculations. Phys Med Biol 2007, 52: 1363. 10.1088/0031-9155/52/5/011

3. Koper PC, Jansen P, van Putten W, van Os M, Wijnmaalen AJ, Lebesque JV, Levendag PC: Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial. Radiother Oncol 2004, 73: 1-9. 10.1016/j.radonc.2004.07.020

4. Dearnaley DP, Khoo VS, Norman AR, Meyer L, Nahum A, Tait D, Yarnold J, Horwich A: Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999, 353: 267-272. 10.1016/S0140-6736(98)05180-0

5. Lips IM, van Gils CH, Kotte AN, van Leerdam ME, Franken SP, van der Heide UA, van Vulpen M: A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2012, 83: 653-660. 10.1016/j.ijrobp.2011.07.030

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram Definition;International Journal of Radiation Oncology*Biology*Physics;2023-12

2. Radiotherapy dose-distribution to the perirectal fat space (PRS) is related to gastrointestinal control-related complications;Clinical and Translational Radiation Oncology;2017-12

3. Investigation of fusion dose distribution for locally advanced cervical cancer under different bladder statuses for intensity-modulated radiotherapy combined with intracavitary brachytherapy;Precision Radiation Oncology;2017-06

4. Diisopropylamine dichloroacetate enhances radiosensitization in esophageal squamous cell carcinoma by increasing mitochondria-derived reactive oxygen species levels;Oncotarget;2016-09-08

5. Independent external validation of predictive models for urinary dysfunction following external beam radiotherapy of the prostate: Issues in model development and reporting;Radiotherapy and Oncology;2016-08